150256-93-2

Upstream product

• 150256-92-1 ethyl 2-<(4-bromo-2-fluorophenyl)methyl>-2,3-dihydro-3-ethoxy-1,2-benzisothiazole-3-carboxylate 1,1-dioxide 
• 2512-24-5 N-tert-butylbenzenesulfonamide 
• 98-09-9 benzenesulfonyl chloride 
• 150256-91-0 ethyl 5-methylbenzo[d]isothiazole-3-carboxylate 1,1-dioxide 
• 150256-89-6 ethyl 2-<1,1-dimethylethyl>-2,3-dihydro-3-hydroxy-1,2-benzisothiazole-3-carboxylate 1,1-dioxide 

Downstream Products

• 150256-94-3 2-<(4-bromo-2-fluorophenyl)methyl>-2,3-dihydro-3-hydroxy-1,2-benzisothiazole-3-carboxamide 1,1-dioxide 

Relevant academic research and scientific papers

Synthesis of Spiro(oxazolidinediones): Spiro-2',3(2H),4'-triones and Spiro-2',4'-dione 1,1-Dioxides

Members of two novel families of spiro(oxazolidinediones) have been prepared.Spiro-2',3(2H),4'-triones (4) were synthesized from the corresponding 1-hydroxy-1-carboethoxyethylisoindol-3-one (7) or (10) or their primary amide

Spiro[1,2-benzisothiazole-3(2H),5'-oxazolidine]-2',4'-dione 1,1-dioxides as antihyperglycemic agents

This invention relates to novel spiro[1,2-benzisothiazole-3(2H),5'-oxazolidine]-2',4'-dione 1,1-dioxides characterized by the general formula (I), STR1 wherein R is lower alkyl containing 1 to 6 carbon atoms, cycloalkyl containing 5 to 6 carbon atoms, all